WARNINGS SECTION
- If you are pregnant, breastfeeding or taking medications consult a healthcare practitioner before use.
- Keep out of reach of children.
- Do not use if seal is missing or broken.
BioCell Salts
- Manufacturer
- ABCO Laboratories, Inc.
- Effective date
- 2015-07-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:06:46
Label at a glance#
ProductBioCell Salts
Active ingredientCALCIUM FLUORIDE, CALCIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM PHOSPHATE, FERRUM PHOSPHORICUM, POTASSIUM SULFATE, SODIUM CHLORIDE, SODIUM SULFATE, MAGNESIUM PHOSPHATE ANHYDROUS, SODIUM PHOSPHATE, SILICON DIOXIDE, ADENOSINE TRIPHOSPHATE, BOS TAURUS PARATHYROID GLAND, BOS TAURUS HYPOTHALAMUS
Label structure8 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
WATER:REVERSE OSMOSI, ETHYL ALCOHOL:GRAIN:190 PROOF, GLYCERINE.
OTC - ACTIVE INGREDIENT SECTION
Calcarea Flourica 6x, Calcarea Sulphurica 3x, Kali Muriaticum 3x, Calcarea Phosphoricum 3x, Ferrum Phosphoricum 3x, Kali Sulphuricum 3x, Natrum Muriaticum 6x, Natrum Sulphuricum 3x, Magnesium Phosphorica 3x, Natrum Phosphorica 3x, Silicea 6x, AATP 5x, Parathyroid 6c, Hypothalamus 6c.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN!
DOSAGE & ADMINISTRATION SECTION
- One full dropper 2x daily or as directed by a healthcare practitioner.
- Shake well before use.
OTC - PURPOSE SECTION
Homeopathic Minerals
INDICATIONS & USAGE SECTION
Dietary Suppliment.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54118-7134-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f66a-f424-e053-dadaa90a57ce | BioCell Salt |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54118-7134-2 | BioCell Salts | 60 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54118-7134 | BIOCELL SALTS (BIOCELL SLATS) SOLUTION/ DROPS [ABCO LABORATORIES, INC.] | 1 | Legacy NDC, 1 package rows | 20150715_3eaa40ae-c8db-47f6-a1c6-3a02d76bc56f.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE TRIPHOSPHATE | ACTIVE INGREDIENT | 8L70Q75FXE | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| BOS TAURUS PARATHYROID GLAND | ACTIVE INGREDIENT | SMV71DDI4T | 1 | |
| CALCIUM FLUORIDE | ACTIVE INGREDIENT | O3B55K4YKI | 1 | |
| CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 97Z1WI3NDX | 1 | |
| CALCIUM SULFATE | ACTIVE INGREDIENT | WAT0DDB505 | 1 | |
| FERRUM PHOSPHORICUM | ACTIVE INGREDIENT | 91GQH8I5F7 | 1 | |
| MAGNESIUM PHOSPHATE ANHYDROUS | ACTIVE INGREDIENT | XMK14ETW2D | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| POTASSIUM SULFATE | ACTIVE INGREDIENT | 1K573LC5TV | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM PHOSPHATE | ACTIVE INGREDIENT | SE337SVY37 | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| ADENOSINE TRIPHOSPHATE | ACTIVE MOIETY | 8L70Q75FXE | 1 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| BOS TAURUS PARATHYROID GLAND | ACTIVE MOIETY | SMV71DDI4T | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COLLOIDAL SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| FERROSOFERRIC PHOSPHATE | ACTIVE MOIETY | 91GQH8I5F7 | 1 | |
| FLUORIDE ION | ACTIVE MOIETY | Q80VPU408O | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 1 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- BioCell Salts
- BioCell Slats
- CALCIUM FLUORIDE
- FLUORIDE ION
- CALCIUM SULFATE
- CALCIUM CATION
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- CALCIUM PHOSPHATE
- FERRUM PHOSPHORICUM
- FERROSOFERRIC PHOSPHATE
- POTASSIUM SULFATE
- SULFATE ION
- SODIUM CHLORIDE
- CHLORIDE ION
- SODIUM SULFATE
- SODIUM SULFATE ANHYDROUS
- MAGNESIUM PHOSPHATE ANHYDROUS
- MAGNESIUM CATION
- SODIUM PHOSPHATE
- PHOSPHATE ION
- SILICON DIOXIDE
- COLLOIDAL SILICON DIOXIDE
- ADENOSINE TRIPHOSPHATE
- BOS TAURUS PARATHYROID GLAND
- BOS TAURUS HYPOTHALAMUS
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 54118-7134 | 54118-7134-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM FLUORIDE | O3B55K4YKI | ACTIB |
| CALCIUM SULFATE | WAT0DDB505 | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| CALCIUM PHOSPHATE | 97Z1WI3NDX | ACTIB |
| FERRUM PHOSPHORICUM | 91GQH8I5F7 | ACTIB |
| POTASSIUM SULFATE | 1K573LC5TV | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| SODIUM SULFATE | 0YPR65R21J | ACTIB |
| MAGNESIUM PHOSPHATE ANHYDROUS | XMK14ETW2D | ACTIB |
| SODIUM PHOSPHATE | SE337SVY37 | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| ADENOSINE TRIPHOSPHATE | 8L70Q75FXE | ACTIB |
| BOS TAURUS PARATHYROID GLAND | SMV71DDI4T | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c9311f00-e85a-4029-af87-f90c637bbc08 | 3eaa40ae-c8db-47f6-a1c6-3a02d76bc56f | 2015-07-14 | Warnings | c9311f00-e85a-4029-af87-f90c637bbc08 3eaa40ae-c8db-47f6-a1c6-3a02d76bc56f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.